Examination of individuals with prediabetes and established diabetes for early signs of diabetic retinopathy.
Eligibility
Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria:
* Voluntary adults
* Aged between 18 and 80 years
* Understanding of the study explanations and instructions
* Prediabetes (defined by elevated fasting glucose 100-125 mg/dL and/or 2-hour glucose in the oral glucose tolerance test of 140-199 mg/dL and/or HbA1c of 5.7-6.4%)
* manifest diabetes (all types of diabetes according to Ahlqvist)
Exclusion Criteria:
* participants unable to give consent
* Those who do not agree to be informed about incidentally detected pathological findings
* Uncontrolled arterial hypertension (Stage III) despite multiple antihypertensive medications
* Eye diseases that impair the interpretability of the fundus examination
Primary outcome measure(s)
Assessment of retinal changes — Day 1 Assessment of retinal changes in individuals with prediabetes and diabetes, quantified using an AI algorithm.
Trial sites (1)
Facility
City
Region
Status
University Hospital Tuebingen, Dep. Diabetology
Tübingen
Germany
More University Hospital Tuebingen trials in Germany
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.